Breast-to-brain metastasis: a focus on the pre-metastatic niche

Abstract

Metastatic disease is the cause for 90% of breast cancer mortalities. For those 10%-20% of patients whose breast cancer metastasizes to the central nervous system, the one-year survival rate is just 20%. Both histology and molecular subtype have a correlation with the site of tumor metastasis, indicating an inherent preferential aspect to metastatic colony formation. The molecular differences between breast cancers may determine the site of metastasis through priming of the premetastatic niche in that site: cell surface molecules, exosomes released from the primary tumor, and soluble factors secreted from both the primary tumor and resident cells within the premetastatic niche all contribute to altering the premetastatic niche to be more favorable for the circulating tumor cells, allowing for cell invasion and growth. Here, we review breast to brain metastasis with a focus on the premetastatic niche. We discuss the secreted factors and exosomes that prime the premetastatic niche within the brain by instigating crosstalk between the resident cells of the brain microenvironment. We report on the individual roles that microglia, astrocytes, pericytes, neurons, and endothelial cells may have in the formation and maintenance of the premetastatic niche.

Keywords

Niche / metastasis / breast cancer / brain

References

[1] Cancer Facts & Figures 2020. Atlanta, GA: American Cancer Society; 2020.

[2] National Cancer Institute. Cancer Stat Facts: Female Breast Cancer. Available from: https://seer.cancer.gov/statfacts/html/breast.html. [Last accessed on 27 May 2021]

[3] Weigelt B,van 't Veer LJ.Breast cancer metastasis: markers and models.Nat Rev Cancer2005;5:591-602

[4] Chaffer CL.A perspective on cancer cell metastasis.Science2011;331:1559-64

[5] Chen W,Liu H.Organotropism: new insights into molecular mechanisms of breast cancer metastasis.NPJ Precis Oncol2018;2:4 PMCID:PMC5871901

[6] Engel J,Aydemir U.Determinants and prognoses of locoregional and distant progression in breast cancer.Int J Radiat Oncol Biol Phys2003;55:1186-95

[7] Niwińska A,Pogoda K.Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).Ann Oncol2010;21:942-8

[8] Chen MT,Zhao Y.Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis.Sci Rep2017;7:9254 PMCID:PMC5569011

[9] Wu Q,Zhu S.Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study.Oncotarget2017;8:27990-6 PMCID:PMC5438624

[10] Gong Y,Ji P,Shao ZM.Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study.Sci Rep2017;7:45411 PMCID:PMC5366953

[11] Gu Y,Zou X,Yi L.Prognostic value of site-specific metastases and surgery in de novo stage IV triple-negative breast cancer: a population-based analysis.Med Sci Monit2020;26:e920432 PMCID:PMC7034402

[12] Zeeshan R.Cancer metastasis - tricks of the trade.Bosn J Basic Med Sci2017;17:172-82 PMCID:PMC5581965

[13] Obenauf AC.Surviving at a distance: organ-specific metastasis.Trends Cancer2015;1:76-91 PMCID:PMC4673677

[14] Steeg PS,Smith QR.Brain metastases as preventive and therapeutic targets.Nat Rev Cancer2011;11:352-63 PMCID:PMC7351203

[15] Massagué J.Metastasis-initiating cells and ecosystems.Cancer Discov2021;11:971-994 PMCID:PMC8030695

[16] Pereira ER,Seano G.Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice.Science2018;359:1403-7 PMCID:PMC6002772

[17] Heitz F,Lueck HJ.Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.Eur J Cancer2009;45:2792-8

[18] Heitz F,Harter P.Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival.Ann Oncol2011;22:1571-81

[19] Miller KD,Haney LG.Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.Ann Oncol2003;14:1072-7

[20] Niikura N,Masuda N.Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.Breast Cancer Res Treat2014;147:103-12

[21] Pestalozzi BC,Price KN.International Breast Cancer Study Group (IBCSG)Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Ann Oncol2006;17:935-44

[22] Weil RJ,Bronder JL,Steeg PS.Breast cancer metastasis to the central nervous system.Am J Pathol2005;167:913-20 PMCID:PMC1603675

[23] Kennecke H,Woods R.Metastatic behavior of breast cancer subtypes.J Clin Oncol2010;28:3271-7

[24] Smid M,Zhang Y.Subtypes of breast cancer show preferential site of relapse.Cancer Res2008;68:3108-14

[25] Wu T.Tumor microenvironment and therapeutic response.Cancer Lett2017;387:61-8

[26] Arciero CA,Jiang R.ER(+)/HER2(+) breast cancer has different metastatic patterns and better survival than ER(-)/HER2(+) breast cancer.Clin Breast Cancer2019;19:236-45

[27] Carter CL,Henson DE.Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.Cancer1989;63:181-7

[28] Koscielny S,Lê MG.Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination.Br J Cancer1984;49:709-15 PMCID:PMC1976833

[29] Ross JS,Linette GP.The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.Oncologist2003;8:307-25

[30] Hellman S.Karnofsky Memorial Lecture. Natural history of small breast cancers.J Clin Oncol1994;12:2229-34

[31] Rosen PP,Saigo PE,Hellman S.Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.J Clin Oncol1989;7:1239-51

[32] Page DL.Prognosis and breast cancer. Recognition of lethal and favorable prognostic types.Am J Surg Pathol1991;15:334-49

[33] Laura S,Ung O.Tumour size as a predictor of axillary node metastases in patients with breast cancer.ANZ J Surg2006;76:1002-6

[34] Sivaramakrishna R.Detection of breast cancer at a smaller size can reduce the likelihood of metastatic spread: a quantitative analysis.Acad Radiol1997;4:8-12

[35] Caswell DR.The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.BMC Med2017;15:133 PMCID:PMC5514532

[36] Foulds L.The natural history of cancer.J Chronic Dis1958;8:2-37

[37] Fidler IJ.The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.Nat Rev Cancer2003;3:453-8

[38] Pontén J.Natural history of breast cancer.Acta Oncol1990;29:325-9

[39] Sopik V.The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.Breast Cancer Res Treat2018;170:647-56 PMCID:PMC6022519

[40] Narod SA.Is invasion a necessary step for metastases in breast cancer?.Breast Cancer Res2018;169:9-23 PMCID:PMC5882625

[41] Schlicker A,Beumer IJ.Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.Int J Cancer2020;147:2303-15

[42] Priedigkeit N,Chen Y.Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases.JAMA Oncol2017;3:666-71 PMCID:PMC5508875

[43] Brastianos PK,Santagata S.Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets.Cancer Discov2015;5:1164-77 PMCID:PMC4916970

[44] Wei S.Surviving at a distant site: The organotropism of metastatic breast cancer.Semin Diagn Pathol2018;35:108-11

[45] Oehrlich NE,Papendorf F.Clinical outcome of brain metastases differs significantly among breast cancer subtypes.Oncol Lett2017;14:194-200 PMCID:PMC5494902

[46] Kim YJ,Kim IA.Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.J Cancer Res Clin Oncol2018;144:1803-16

[47] Barnholtz-Sloan JS,Davis FG,Lai P.Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.J Clin Oncol2004;22:2865-72

[48] Sakhuja S,Wilson LE.Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset.Breast Cancer Res Treat2021;186:509-18

[49] Malladi S,Jin X.Metastatic latency and immune evasion through autocrine inhibition of WNT.Cell2016;165:45-60 PMCID:PMC4808520

[50] Risson E,Maguer-Satta V.The current paradigm and challenges ahead for the dormancy of disseminated tumor cells.Nat Cancer2020;1:672-80 PMCID:PMC7929485

[51] Baram T,Ben-Yaakov H.Inflammation-driven breast tumor cell plasticity: stemness/EMT, therapy resistance and dormancy.Front Oncol2020;10:614468 PMCID:PMC7873936

[52] Bos PD,Nadal C.Genes that mediate breast cancer metastasis to the brain.Nature2009;459:1005-9 PMCID:PMC2698953

[53] Maiti A.Autophagy-mediated tumor cell survival and progression of breast cancer metastasis to the brain.J Cancer2021;12:954-64 PMCID:PMC7797661

[54] Hebert JD,Naba A.Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches.Cancer Res2020;80:1475-85 PMCID:PMC7127975

[55] Semenza GL.Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.EMBO J2017;36:252-9 PMCID:PMC5286373

[56] Schild T,Blenis J.Unique metabolic adaptations dictate distal organ-specific metastatic colonization.Cancer Cell2018;33:347-54 PMCID:PMC5889305

[57] Lah TT,Breznik B.Brain malignancies: Glioblastoma and brain metastases.Semin Cancer Biol2020;60:262-73

[58] Elia I.Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.Nat Metab2021;3:21-32 PMCID:PMC8097259

[59] Sharma MK,Singh G.Cancer cells release glutamate via the cystine/glutamate antiporter.Biochem Biophys Res Commun2010;391:91-5

[60] Blazquez R,Wenske B.LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.Int J Cancer2020;146:3170-83

[61] Gao Y,Wang H,Rosen JM.Metastasis organotropism: redefining the congenial soil.Dev Cell2019;49:375-91 PMCID:PMC6506189

[62] Masui K,Mischel PS.mTORC2 dictates Warburg effect and drug resistance.Cell Cycle2014;13:1053-4 PMCID:PMC4013152

[63] Pedrosa RMSM,Soffietti R.Breast cancer brain metastasis: molecular mechanisms and directions for treatment.Neuro Oncol2018;20:1439-49 PMCID:PMC6176797

[64] Hoshino A,Shen TL.Tumour exosome integrins determine organotropic metastasis.Nature2015;527:329-35 PMCID:PMC4788391

[65] Kaplan RN,Lyden D.Preparing the "soil": the premetastatic niche.Cancer Res2006;66:11089-93 PMCID:PMC2952469

[66] Kaplan RN,Zacharoulis S.VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.Nature2005;438:820-7 PMCID:PMC2945882

[67] Aguado BA,Rao SS,Shea LD.Engineering the pre-metastatic niche.Nat Biomed Eng2017;1:10077 PMCID:PMC5628747

[68] Guo Y,Liu J.Effects of exosomes on pre-metastatic niche formation in tumors.Mol Cancer2019;18:39 PMCID:PMC6413442

[69] Liu Y.Characteristics and significance of the pre-metastatic niche.Cancer Cell2016;30:668-81

[70] Peinado H,Matei IR.Pre-metastatic niches: organ-specific homes for metastases.Nat Rev Cancer2017;17:302-17

[71] Brandi J,Speziali G,Marengo E.Proteomic approaches to decipher cancer cell secretome.Semin Cell Dev Biol2018;78:93-101

[72] Witzel I,Pantel K,Wikman H.Breast cancer brain metastases: biology and new clinical perspectives.Breast Cancer Res2016;18:8 PMCID:PMC4717619

[73] Klemm F,Bowman RL.Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells.Cell2020;181:1643-60.e17

[74] Carvalho R,Ribeiro AS.Impact of breast cancer cells secretome on the brain metastatic niche remodeling.Semin Cancer Biol2020;60:294-301

[75] Lull ME.Microglial activation and chronic neurodegeneration.Neurotherapeutics2010;7:354-65 PMCID:PMC2951017

[76] Boche D,Nicoll JA.Review: activation patterns of microglia and their identification in the human brain.Neuropathol Appl Neurobiol2013;39:3-18

[77] Sidani M,Xue C,Condeelis J.Probing the microenvironment of mammary tumors using multiphoton microscopy.J Mammary Gland Biol Neoplasia2006;11:151-63

[78] Le W,Xie W,He Y.Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.J Neurosci2001;21:8447-55 PMCID:PMC6762816

[79] Li R,Fang D.(-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury.J Neurosci Res2004;78:723-31

[80] Block ML,Hong JS.Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.Nat Rev Neurosci2007;8:57-69

[81] Butovsky O,Ben-Yaakov K.Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective.Mol Cell Neurosci2005;29:381-93

[82] Zhou X,Krieglstein K.TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia.J Neuroinflammation2012;9:210 PMCID:PMC3488564

[83] Benbenishty A,Cottarelli A.Prophylactic TLR9 stimulation reduces brain metastasis through microglia activation.PLoS Biol2019;17:e2006859 PMCID:PMC6469801

[84] Pukrop T,Chuang HN.Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way.Glia2010;58:1477-89

[85] Xing F,Wu SY.Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis.Cancer Res2018;78:4316-30 PMCID:PMC6072593

[86] Loda A.Xist RNA in action: past, present, and future.PLoS Genet2019;15:e1008333 PMCID:PMC6752956

[87] Friebel E,Unger S.Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes.Cell2020;181:1626-42.e20

[88] Kloosterman DJ.Mapping the uncharted territories of human brain malignancies.Cell2020;181:1454-7

[89] Guldner IH,Yang L.CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10.Cell2020;183:1234-48.e25 PMCID:PMC7704908

[90] Schulz M,Niesel K.Cellular and molecular changes of brain metastases-associated myeloid cells during disease progression and therapeutic response.iScience2020;23:101178 PMCID:PMC7262568

[91] Freeman MR.Specification and morphogenesis of astrocytes.Science2010;330:774-8 PMCID:PMC5201129

[92] Da Silva L,Smart CE.HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.Breast Cancer Res2010;12:R46 PMCID:PMC2949633

[93] Lorger M.Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.Am J Pathol2010;176:2958-71 PMCID:PMC2877856

[94] Seike T,Yamakawa Y.Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.Clin Exp Metastasis2011;28:13-25 PMCID:PMC2998640

[95] Lin Q,Fan D.Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.Neoplasia2010;12:748-54 PMCID:PMC2933695

[96] Valiente M,Jin X.Serpins promote cancer cell survival and vascular co-option in brain metastasis.Cell2014;156:1002-16 PMCID:PMC3988473

[97] Voura EB,Montgomery AM.Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.Mol Biol Cell2001;12:2699-710 PMCID:PMC59705

[98] Silletti S,Sheppard D.et al. Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment.J Cell Biol2000;149:1485-502 PMCID:PMC2175144

[99] Xing F,Okuda H.Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain.EMBO Mol Med2013;5:384-96 PMCID:PMC3598079

[100] Nam DH,Kim S.Activation of notch signaling in a xenograft model of brain metastasis.Clin Cancer Res2008;14;4059-66

[101] Shen Q. Notch signaling and the breast cancer microenvironment. In: Reichrath J, Reichrath S, editors. Notch signaling in embryology and cancer. Cham: Springer; 2021. p. 183-200.

[102] Meurette O. Shaping of the tumor microenvironment by notch signaling. In: Birbrair A, editor. Tumor Microenvironment. Cham: Springer; 2020. p. 1-16.

[103] Marchetti D,Blust J,Greiter-Wilke A.p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells.J Cell Biochem2004;91:206-15

[104] Marchetti D,Shen R.Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.Cancer Res2000;60:4767-70

[105] Nakajima M,Nicolson GL.Heparanases and tumor metastasis.J Cell Biochem1988;36:157-67

[106] Vlodavsky I,Ilan N.Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications.Rambam Maimonides Med J2011;2:e0019 PMCID:PMC3678787

[107] Alhusban L,Alhusban A.ProBDNF is a novel mediator of the interaction between MDA-MB-231 breast cancer cells and brain microvascular endothelial cells.Curr Mol Med2020;

[108] Denkins Y,Roy M.Brain metastases in melanoma: roles of neurotrophins.Neuro Oncol2004;6:154-65 PMCID:PMC1871977

[109] Louie E,Coomes A,Tsirka S.Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis.Oncogene2013;32:4064-77 PMCID:PMC3998718

[110] Priego N,Monteiro C.STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis.Nat Med2018;24:1024-35

[111] Hosonaga M,Arima Y.Molecular and cellular mechanisms underlying brain metastasis of breast cancer.Cancer Metastasis Rev2020;39:711-20 PMCID:PMC7497304

[112] Bergers G.The role of pericytes in blood-vessel formation and maintenance.Neuro Oncol2005;7:452-64 PMCID:PMC1871727

[113] Cheng L,Zhou W.Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.Cell2013;153:139-52 PMCID:PMC3638263

[114] Cooke VG,Keskin D.Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.Cancer Cell2012;21:66-81 PMCID:PMC3999522

[115] Keskin D,Cooke VG.Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.Cell Rep2015;10:1066-81 PMCID:PMC4342328

[116] Molnár K,Fazakas C.Pericyte-secreted IGF2 promotes breast cancer brain metastasis formation.Mol Oncol2020;14:2040-57 PMCID:PMC7463359

[117] Lyle LT,Adkins CE.Alterations in pericyte subpopulations are associated with elevated blood-tumor barrier permeability in experimental brain metastasis of breast cancer.Clin Cancer Res2016;22:5287-99 PMCID:PMC5093086

[118] Zeng Q,Zhang P.Synaptic proximity enables NMDAR signalling to promote brain metastasis.Nature2019;573:526-31 PMCID:PMC6837873

[119] Schulz M,Niesel K,Sevenich L.Microenvironmental regulation of tumor progression and therapeutic response in brain metastasis.Front Immunol2019;10:1713 PMCID:PMC6667643

[120] Soto MS,Anthony DC.Functional role of endothelial adhesion molecules in the early stages of brain metastasis.Neuro Oncol2014;16:540-51 PMCID:PMC3956349

[121] Ng LG,Hidalgo A.Heterogeneity of neutrophils.Nat Rev Immunol2019;19:255-65

[122] Mantovani A,Costantini C.Neutrophils in the activation and regulation of innate and adaptive immunity.Nat Rev Immunol2011;11:519-31

[123] Wu M,Tan Z,Liu X.Neutrophil: a new player in metastatic cancers.Front Immunol2020;11:565165 PMCID:PMC7546851

[124] Zhang L,Wei Y.Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases.Sci Transl Med2020;12:eaaz5387 PMCID:PMC7948522

[125] Hyun YM,Choi WS.Endogenous DEL-1 restrains melanoma lung metastasis by limiting myeloid cell-associated lung inflammation.Sci Adv2020;6:eabc4882 PMCID:PMC7673713

[126] Liu Y,Ikeura M.Premetastatic soil and prevention of breast cancer brain metastasis.Neuro Oncol2013;15:891-903 PMCID:PMC3688013

[127] Tomonobu N,Sakaguchi M.et al. S100 soil sensor receptors and molecular targeting therapy against them in cancer metastasis.Transl Oncol2020;13:100753 PMCID:PMC7078545

[128] Sinha P,Foell D,Ostrand-Rosenberg S.Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.J Immunol2008;181:4666-75 PMCID:PMC2810501

[129] Feinauer MJ,Berghoff AS.Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model.Blood2021;137:1219-32

[130] Malanchi I,Susanto E.Interactions between cancer stem cells and their niche govern metastatic colonization.Nature2011;481:85-9

[131] Fong MY,Liu L.Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.Nat Cell Biol2015;17:183-94 PMCID:PMC4380143

[132] Balaj L,Dai L.Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.Nat Commun2011;2:180 PMCID:PMC3040683

[133] Skog J,van Rijn S.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat Cell Biol2008;10:1470-6 PMCID:PMC3423894

[134] Théry C,Segura E.Membrane vesicles as conveyors of immune responses.Nat Rev Immunol2009;9:581-93

[135] Raposo G.Extracellular vesicles: exosomes, microvesicles, and friends.J Cell Biol2013;200:373-83 PMCID:PMC3575529

[136] Peinado H,Lyden D.The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.Semin Cancer Biol2011;21:139-46

[137] Choi DS,Kim YK.Proteomics, transcriptomics and lipidomics of exosomes and ectosomes.Proteomics2013;13:1554-71

[138] Valadi H,Bossios A,Lee JJ.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat Cell Biol2007;9:654-9

[139] Thakur BK,Becker A.Double-stranded DNA in exosomes: a novel biomarker in cancer detection.Cell Res2014;24:766-9 PMCID:PMC4042169

[140] Zhang L,Yao J.Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.Nature2015;527:100-4 PMCID:PMC4819404

[141] Arnold J,Blechner C.Tubulin Tyrosine Ligase Like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis.J Exp Clin Cancer Res2020;39:205 PMCID:PMC7528497

[142] Morad G,Hagedorn EJ.Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis.ACS Nano2019;13:13853-65 PMCID:PMC7169949

[143] Lu Y,Li L.Exosomes derived from brain metastatic breast cancer cells destroy the blood-brain barrier by carrying lncRNA GS1-600G8.5.Biomed Res Int2020;2020:7461727 PMCID:PMC7165326

[144] Rodrigues G,Kenific CM.Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.Nat Cell Biol2019;21:1403-12 PMCID:PMC7354005

[145] Kp M,Biswas D.The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas.Brain Tumor Pathol2021;38:96-108